I have been diagnosed with prostate cancer. Fortunately, I was placed on a treatment plan, and since then, I've been fighting this battle However, countless others face a graver reality — one that could be changed with the immediate approval of a life-saving drug: Abiraterone.

Abiraterone has been proven to reduce the risk of prostate cancer returning by an impressive 50% and remarkably improves survival rates by 40%. Yet, despite its undeniable benefits and affordability at just £2.50 per day, its approval by NICE and the NHS remains tangled in bureaucratic red tape. This delay is unacceptable, especially when every day counts.

What is even more disheartening is that Abiraterone is already approved and available in Scotland and Wales, saving lives that could otherwise be lost. Meanwhile, here in parts of the UK, 13 men succumb to this disease every week — deaths that could be prevented if this drug were accessible without delay.

Prostate cancer should not be a death sentence, especially when a viable solution is within reach. The unnecessary bureaucracy must be addressed so that men diagnosed with prostate cancer can be given the fighting chance they deserve.

We urge decision-makers to set aside obstacles and expedite the approval process for Abiraterone under NICE and the NHS. It's a simple, affordable, and effective treatment that many lives could depend on. Join us in this vital cause to make Abiraterone available to those who need it the most.

Help us make a difference in the lives of countless men. Sign this petition and demand action now.